Premium
Endogenous material in brain inhibiting [ 3 H]nicotine and [ 3 H]acetylcholine binding
Author(s) -
Sershen H.,
Reith M. E. A.,
Hashim A.,
Lajtha A.
Publication year - 1984
Publication title -
journal of neuroscience research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.72
H-Index - 160
eISSN - 1097-4547
pISSN - 0360-4012
DOI - 10.1002/jnr.490120405
Subject(s) - chemistry , nicotine , sephadex , imipramine , acetylcholine receptor , affinity chromatography , binding site , nicotinic agonist , ligand (biochemistry) , biochemistry , stereochemistry , receptor , enzyme , medicine , alternative medicine , pathology
The supernatant obtained from mouse brain homogenates contains material that inhibits the saturable binding of [ 3 H]nicotine in mouse cerebral cortex. This inhibitory material was further purified by heat denaturation, ultrafiltration through an Amicon PM‐10 membrane filter, and gel chromatography on Sephadex G‐10. The material inhibited the binding of [ 3 H]acetylcholine with the same potency as it did that of [ 3 H]nicotine. It also had some affinity for the sites that specifically bind [ 3 H]D‐Ala, D‐Leu enkephalin, but had much lower affinity for the binding sites for [ 3 H]quinuclidinyl benzilate (QNB), [ 3 H]spiroperidol, [ 3 H]naloxone, or [ 3 H]imipramine. Acid hydrolysis destroyed the activity. These preliminiary results suggest the presence in brain of “nicotinelike” substances, one of which may be the endogenous ligand for the sites that specifically bind [ 3 H]nicotine.